5th highest TB burden country in the world.
Accounts for 6.2% of global TB cases.
687,000 new cases were officially notified.
Probabilistic models suggest a case notification rate of roughly 250 suspected cases per 100,000 population in sampled high-burden areas
A particularly severe dimension of the epidemic is the rise of drug-resistant strains, which are more complex and costly to treat.
15,000 cases were identified as drug-resistant.
DR-TB requires prolonged treatment with multiple antibiotics, as single-drug regimens are ineffective and can worsen resistance
Ahmad Malik, CEO of Charity Doings Foundation, brings profound, field-tested experience in TB program management, particularly from his work in the northern belt of Pakistan. His expertise has been pivotal in shaping effective public health strategies through his roles as Program Coordinator for initiatives supported by Mercy Corps, the Global Fund, and the Bill & Melinda Gates Foundation.
His key contributions include:
Championing Technology: Advocating for and contributing to the implementation of digital health tools like DHIS-2. This has been instrumental in improving TB case identification, data management, and strengthening Pakistan’s national TB surveillance system.
Raising Awareness: Actively working to educate affected demographics, breaking down stigma and encouraging early testing and treatment adherence.
The process is designed to be efficient and patient-centric:
Case Identification: The Hub lab receives suspected TB cases from the surrounding communities.
Thorough Diagnosis: It conducts initial screening and sample collection to ensure accurate detection.
Referral for Treatment: Confirmed or complex cases are seamlessly transferred to the reference laboratory in Lasbela, where comprehensive treatment and medication are initiated.
CDF will authored the definitive guidelines for the proper execution of TB rapid diagnostic tests. This document will serve as the national standard, ensuring that RDTs are used correctly, safely, and effectively across both public and private sector health facilities. It will cover technical protocols, quality assurance measures, and best practices to guarantee reliable results.
A diagnosis is only as good as the sample it’s tested on. CDF will design a complete, field-ready logistics protocol for specimen management. This will detail every step of the process, including:
⦁ Safe and sterile sample collection in field settings.
⦁ Proper packaging and labeling to ensure specimen integrity.
⦁ A temperature-controlled transportation chain from remote testing sites to designated laboratories.
This protocol will be crucial for maintaining the quality of samples collected in hard-to-reach areas, ensuring that distance does not compromise diagnostic accuracy.
To ensure the guidelines are not just written but are also easily understood and implemented, CDF will produce a series of highly engaging educational videos. This digital user manual will visually guide healthcare workers through the entire process:
⦁ Device Operation: Clear, step-by-step demonstrations on how to use the RDT devices.
⦁ End-to-End Workflow: A visual journey from setting up a testing station in the field to sample processing in the lab.
⦁ Communicating Results: Sensitive and effective guidance on how to deliver diagnostic results to patients and link them to the care pathway.